publication venue for
- Real-world analysis of polycythemia vera treatment reveals nonadherence to NCCN guidelines in a large proportion of patients.. 2. 2025
- A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemia.. 2. 2025
- Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis.. 2. 2025
- A feedforward loop between ACLY and MYC supports T-ALL progression in vivo.. 2. 2025
- Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma.. 1. 2024